Risk factors of adverse drug reaction from non-steroidal anti-inflammatory drugs in Shanghai patients with arthropathy

Acta Pharmacologica Sinica

Volumn 25, Issue 3, 2004, Pages 357-365

  Shi, Wen ^a   Wang, Yong Ming ^a   Li, Shao Li ^b   Yan, Min ^b   Li, Duan ^a   Chen, Bin Yan ^a   Cheng, Neng Neng ^a  

^a FUDAN UNIVERSITY   (China)

^b Food and Drug Administration   (China)

Author keywords

Adverse drug reaction; Non steroidal anti inflammatory drugs; Quality of life; Retrospective studies; Risk factors

Indexed keywords

ACEMETACIN; ACETYLSALICYLIC ACID; ARTHROTEC; DICLOFENAC; IBUPROFEN; INDOMETACIN; MELOXICAM; NABUMETONE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PIROXICAM; SULINDAC;

ABDOMINAL DISCOMFORT; ACID BELCHING; ADULT; ADVERSE DRUG REACTION; AGED; ALCOHOL CONSUMPTION; ARTHROPATHY; ARTICLE; CHINA; CLOUDED VISION; CONSTIPATION; DIARRHEA; DIETARY INTAKE; DIZZINESS; DYSPEPSIA; FACE EDEMA; FAMILY HISTORY; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HEALTH SURVEY; HEART PALPITATION; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DYSFUNCTION; LEG EDEMA; LEUKOPENIA; LIFESTYLE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; QUALITY OF LIFE; RASH; RISK FACTOR; SMOKING; STOMACH DISCOMFORT; STOMACH DISEASE; STOMACH DISTENSION; STOMACH HEMORRHAGE; STOMACH PAIN; VISUAL IMPAIRMENT; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BUTANONES; CHILD; DICLOFENAC; DIZZINESS; EXANTHEMA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPONDYLITIS, ANKYLOSING; STOMACH DISEASES; THIAZINES; THIAZOLES;

EID: 1542344360     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Marie R, Griffin MD. Epidemiology of non-steroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998; 104: 23-8.
2. Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomized double-blind comparison. Lancet 1999; 354: 2106-11.
3. Anna JM, David PF. Rofecoxib, a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis. Drugs 2001; 61: 833-65.
4. Ahmad SR, Kortepeter C, Brinker A. Renal failure associated with the use of celecoxib and rofecoxib. Drug Safety 2002; 25: 537-44.
5. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications. Am J Med 1999; 106: 13-23.
6. Schafer AL. Effects of non-steroidal anti-inflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995; 35: 209-19.
7. Johnson AG, Nguyen TV, Day RO. Do non-steroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 21: 289-300.
8. Heerdink ER. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics Arch Interm Med 1998; 158: 1108-12.
9. Buchanan W, Kean W. Rare side effects of non-steroidal anti-inflammatory drugs. In: Non-steroidal anti-inflammatory drugs, mechanisms and clinical uses. Lewis A, Furst D, editors. New York (NY): Marcel Dekker; 1994. p 217-43.
10. Proscott LF. The hepatotoxicity of non-steroidal anti-inflammatory drugs. In: Side-effects of anti-inflammatory drugs. Rainsford KD, Velo GP, editors. Lancaster (UK): Kluwer Academic; 1992. p 176-87.
11. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991; 91: 213-22.
12. Silverstein FE, Graham DY, Senior JR. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs: a randomized, double blind, placebo-controlled trial. Ann Intern Med 1995; 123: 241-9.
13. McGoldrick D, George RB. Nonnarcotic analgesics: Prevalence and estimated economic impact of toxicities. Ann Pharmacother 1997; 31: 221-7.
14. John P, David H. Consumption of NSAIDs and the development of congestive heart failure in elderly patients. Arch Intern Med 2000; 160: 777-83.
15. McCarthy DM. Comparative toxicity of nonsteroidal anti-inflammatory drugs. Am J Med 1999; 107: 37-46.
16. Davd H, Lynette LY, Luis AG. Variability in risks of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: result of a collaborative meta-analysis. Br Med J 1996; 312: 1563-6.
17. Anne VH, Jules IS, Marleen D. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on cox-2 verse cox-1 in health volunteers. J Clin Pharmacol 2000; 40: 1109-20.
18. McQueen S, Hutton D, Allen A. Gastric and duodenal surface mucus gel thickness in rat: effects of prostaglandins and damaging agents. Am J Physiol 1983; 245: 388.
19. Fries JF. How many quality of life for rheumatoid arthritis patients be enhanced by current and future treatment. Rheumatology (Oxford) 1999; 38: 35-40.
20. Li L, Wang HM, Shen Y. Chinese SF-36 health survey: translation, cultural adaptation, validation, and normalization. J Epidemiol Community Health 2003; 57: 259-63.
21. Hill CL, Parson J, Taylor A. Health related quality of life in a population with arthritis. J Rheumatol 1999; 26: 2029-35.